| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 145,400 | 74,400 | ||
| Trade accounts receivable | 118,000 | 137,000 | ||
| Inventory | 31,600 | 28,700 | ||
| Prepaid taxes | 13,800 | 14,300 | ||
| Prepaid expenses and other current assets | 36,000 | 29,900 | ||
| Total current assets | 344,800 | 284,300 | ||
| Operating lease right-of-use assets | 50,600 | 51,200 | ||
| Property, plant, and equipment, net | 111,400 | 113,000 | ||
| Intangibles, net | 163,100 | 170,100 | ||
| Goodwill | 51,600 | 51,600 | ||
| Other assets | 6,600 | 7,100 | ||
| Total assets | 728,100 | 677,300 | ||
| Current debt | - | 59,400 | ||
| Accounts payable | 31,800 | 30,900 | ||
| Accrued liabilities | 108,300 | 100,600 | ||
| Current maturities of operating lease liabilities | 7,900 | 9,000 | ||
| Total current liabilities | 148,000 | 199,900 | ||
| Unrecognized tax benefits | 1,200 | 1,200 | ||
| Long-term debt | 119,500 | 0 | ||
| Noncurrent operating lease liabilities | 84,900 | 86,200 | ||
| Other long-term liabilities | 1,700 | 1,900 | ||
| Total liabilities | 355,300 | 289,200 | ||
| Common stock, 93.1 and 91.3 shares outstanding at september30, 2025 and december31, 2024, respectively | 900 | 900 | ||
| Additional paid-in capital | 1,486,800 | 1,474,700 | ||
| Accumulated other comprehensive loss | -100 | -100 | ||
| Accumulated deficit | -1,114,800 | -1,087,400 | ||
| Total stockholders' equity | 372,800 | 388,100 | ||
| Total liabilities and stockholders equity | 728,100 | 677,300 | ||
MYRIAD GENETICS INC (MYGN)
MYRIAD GENETICS INC (MYGN)